New MS Drugs are Changing the Game

Multiple sclerosis affects more than 400,000 people in the US. It causes chronic pain, vision disability, numbness, and immobility. There’s been no cure found for MS though there are...

Multiple sclerosis affects more than 400,000 people in the US. It causes chronic pain, vision disability, numbness, and immobility. There’s been no cure found for MS though there are treatments that can help decrease the evolution of the illness that is progressive.

The disease tends to start showing symptoms between the ages of 40 and 15 , the indicators could go a way to get a ttimeand then return . It requires a couple years to the area of the disease. The earlier it’s detected, the easier it is to control.

Ocrevus may be the FDA approved medication in the US, while there are a lot of medications available on the market. It’s the first medication to treat progressive MS.

MS causes the immune system to attack on the nervous system. The damage it causes, because of today, is irreversible and can cause issues with feeling and movement. Ocrevus targets one of those cells. It will help reduce the amount of MS attacks people have done to the nervous system, and finally, slows the disease down. This is.

Estimated to cost $ 65,000 a year, it’s projected to have earnings of 4 billion a year while the medication is more expensive. It seems that the medication would be worth the price if patients are able to make use and life by years or years.

Categories
Medical
No Comment

Leave a Reply

*

*

RELATED BY